Primarily market-linked growth exposure
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
Investors with a long horizon who can tolerate meaningful falls in value.
Share-price volatility, valuation risk, concentration and tracking risk where applicable.
How the money may be invested
Equity and equity related securities of pharmaceutical and healthcare companies- Min 80% and Max 100% Equity & Equity Related Securities of other companies- Min 0% and Max 20% Money Market Instruments and, other liquid instruments, Units of Liquid, Money Market and Overnight Mutual funds - Min 0% and Max 20% Units issued by InvITs - Min 0% and Max 10% Foreign securities including overseas ETFs - Min 0% and Max 20% Units of Gold ETFs & Silver ETFs - Min 0% and Max 20%
- SEBI category
- Thematic Fund
- Fund type
- An open ended equity scheme investing in healthcare and pharmaceutical theme.
- Primary benchmark
- BSE Healthcare TRI
Use the latest monthly portfolio
Top holdings are the largest securities currently owned by the scheme. Names and weights can change every month, so a copied list can become misleading. Open the AMC's current official portfolio or factsheet below and look for this exact fund name.
Manager and scheme tenure
- Fund manager(s)
- Mr. Anandha Padmanabhan Anjeneyan, Mr. Utsav Mehta, Mr. Vivek Sharma and Mr. Puneet Pal
- Manager tenure on this scheme
- Since Mr. Anandha Padmanabhan Anjeneyan - 06.12.2024, Mr. Utsav Mehta - 06.12.2024, Mr. Vivek Sharma - 06.12.2024 and Mr. Puneet Pal - 06.12.2024
- Role / co-management
- Description - Asset classwise we have different Fund Manager. Anandha Padmanabhan Anjeneyan is a Primary Fund Manager for Equity, Utsav Mehta is a Comanage Fund Manager for Equity, Vivek Sharma is a Comanage Fund Manager for Equity and Puneet Pal for Debt.
The tenure above is experience managing this scheme, not the manager's total career experience. For education, qualifications and prior roles, open the latest official AMC factsheet or manager profile below.
Latest NAV records
NAV is a per-unit accounting value. Compare returns, portfolio, risk and cost — never choose a fund only because its NAV looks low.
| Plan / option reported by AMFI | NAV | Date |
|---|---|---|
| PGIM India Healthcare Fund - Direct Plan - Direct Growth | ₹12.4700 | 04 Sep 2026 |
| PGIM India Healthcare Fund - Direct Plan - Direct IDCW | ₹12.4700 | 04 Sep 2026 |
| PGIM India Healthcare Fund - Regular Plan - Regular Growth | ₹12.1000 | 04 Sep 2026 |
| PGIM India Healthcare Fund - Regular Plan - Regular IDCW | ₹12.1000 | 04 Sep 2026 |
What you pay and how money moves
- Stated expense ratio
- Regular 2.58%, Direct 0.93%
- Exit load
- For Exits within 90 days from date of allotment of units: 0.50%; For Exits beyond 90 days from date of allotment of units: NIL.
- Minimum application
- Rs. 5000 · multiples of Rs.1
- SIP frequency
- SIP - Monthly/Quarterly, SWP - Monthly/ Quartely/ Annually, STP -Daily/Weekly/Monthly/Quarterly
- Minimum SIP amount
- SIP - Monthly/Quarterly : 1000, SWP - Monthly/ Quartely/ Annually : 1000, STP -Daily/Weekly/Monthly/Quarterly :1000
- Minimum instalments
- SIP - 5, SWP - 5, STP - 5
How a mutual-fund investment is paid
- Complete KYCIdentity, PAN, bank and contact verification are required.
- Choose route and optionUnderstand direct vs regular and growth vs IDCW before selecting.
- Choose SIP or lump sumSIP uses an automated mandate; lump sum is a one-time payment.
- Receive units at applicable NAVCut-off time, cleared funds and scheme rules determine the applicable NAV.
- Review, do not chaseTrack goal fit, risk, manager/mandate changes, costs and portfolio — not daily noise.
Download and verify at source
The packaged Scheme Summary PDF is the official AMFI file, unchanged. Live AMC links are included for time-sensitive factsheets, top holdings and portfolios.
Source verification date: 06 September 2026. If a live document differs from this page, rely on the newer official document.